Tweet
I was wondering how to interpret the Kmer content graph in fastqc. I have attached it. It seems from my graph that 50% of all reads have the 6 kmers listed ? Is this a normal graph ?
-
-
Is this RNA-seq data?
Following thread may be useful (though it refers to a MiSeq run the issue is applicable to illumina sequencing in general): http://seqanswers.com/forums/showthread.php?t=30448
One more: http://seqanswers.com/forums/showthread.php?t=17219Last edited by GenoMax; 08-13-2013, 11:57 AM. -
Thank you very much, GenoMax, for the links. They are very informative.
This is RNA-Seq. It seems the first 12 or so bases are due to 'random' priming, but I was also wondering about why the lines on the graph stay up at ~50% for the length of the graph ? Random priming would explain the first 12 or so bases, but why the steady % for the rest of the sequence ?Comment
-
-
Thanks again for your help, GenoMax.
My sequence length is only 50 bases and the quality is very good.
From what I read on the linked site, it seems that I have 6 kmers that are 50-fold enriched throughout the length of my sequence. But what does this mean in terms of sample quality ?
If I have 25-30 million reads and there is a 50 fold enrichment of these kmers (most likely I would guess from the adaptor) then how many sequences does that affect ? So, if there were 100,000 sequences in which had adaptor sequence at various positions other than the end of the sequence what would the fold-enrichment be ? 100,000 affected sequences may be enough to make the fold-enrichment high, but they are only a small percentage of the total. On the other hand, if I had a much smaller number of total sequences, then the fold-enrichment may be a problem. So, I guess I want to know how to relate fold-enrichment and total number of sequences in order to tell if the fold-enrichment is a problem or just from an insignificant part of the total.Comment
-
Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...12-16-2024, 07:57 AM -
Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.
Long-Read Sequencing
Long-read sequencing has seen remarkable advancements,...12-02-2024, 01:49 PM
Comment